Home » Topics » BioWorld Science

BioWorld Science
RSS

Sugen-Allergen collaboration in ophthalmic diseases

Oct. 18, 1996

Isis antisense compound and analogues covered by U.S. patent

Oct. 18, 1996

Targeted Genetics receives grant for its HER-2/neu oncogene inhibitor

Oct. 18, 1996

Natural antitumor indanone reported by Sagami

Oct. 18, 1996

Eisai claims RXR agonists

Oct. 18, 1996

New antitumor agents from Sagami

Oct. 18, 1996

VCAM-1 inhibitors from Sagami

Oct. 18, 1996

Banyu reports natural antitumor agent

Oct. 18, 1996

Tyrosine kinase inhibitor developed by Cephalon and TAP enters clinical trials

Oct. 18, 1996

Broader role of VEGF in tumor growth proposed

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...